Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

@article{Tiwari2015AntimicrobialAH,
  title={Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens},
  author={Vishvanath Tiwari and Ranita Roy and Monalisa Tiwari},
  journal={Frontiers in Microbiology},
  year={2015},
  volume={6}
}
Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pathogens which cause respiratory infection, pneumonia and urinary tract infections. The prevalence of this pathogen increases gradually in the clinical setup where it can grow on artificial surfaces… Expand
Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy
TLDR
The classic mechanisms of Acinetobacter AMR are summarized, along with newly-discovered genetic AMR factors and currently available antimicrobial adjuvants that can enhance drug efficacy in the treatment of A. baumannii infections. Expand
Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii.
Acinetobacter baumannii is grouped in the ESKAPE pathogens by Infectious Disease Society of America, which is linked to high degree of morbidity, mortality, and increased costs. The high level ofExpand
Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
TLDR
It can be concluded that polar extract of A. deliciosa can be used to find suitable alternative therapeutic to control biofilm formation by carbapenem resistant strain of Acinetobacter baumannii. Expand
Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii
TLDR
Results demonstrate that ZnO-NP could be developed as alternative therapeutics against A. baumannii, and the proposed mechanism of action of ZNO involves the production of reactive oxygen species, which elevates membrane lipid peroxidation that causes membrane leakage of reducing sugars, DNA, proteins, and reduces cell viability. Expand
Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
TLDR
Better survival of these ESKAPE pathogens in hospital setup can be correlated with differential production of antimicrobial secondary metabolites, which will initiate research that might lead to the discovery of antibiotics from oneESKAPE pathogen that controls the infection of other ESKape pathogens or other pathogens. Expand
An Evaluation of the Antibacterial Properties of Tormentic Acid Congener and Extracts From Callistemon viminalis on Selected ESKAPE Pathogens and Effects on Biofilm Formation
ESKAPE pathogens, namely, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, are responsible for a majorityExpand
Comparative Anti-Bacterial Activity of Differently Capped Silver Nanomaterial on the Carbapenem Sensitive and Resistant Strains ofAcinetobacter baumannii
Acinetobacter baumannii is an opportunistic Gram-negative pathogen causes pneumonia, respiratory infections and urinary tract infections and emerged as a serious pathogen for the immuno-compromisedExpand
Comparative mechanism based study on disinfectants against multidrug‐resistant Acinetobacter baumannii
TLDR
The present results will help in selecting concentrations of different disinfectants for regular use in hospital setups to eradicate the multidrug‐resistant A. baumannii from the hospital setup. Expand
Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies
TLDR
In vitro and in vivo data from the animal model support the use of S. barbata as an alternate drug to treat XDRAB pulmonary infections, however, detailed animal studies and clinical trials are necessary to establish the clinical utility of this drug. Expand
Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell
TLDR
PVP-AgNPs can be developed as a substitute for carbapenem to control the infection caused by carbapENem-resistant A. baumannii. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 149 REFERENCES
Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
TLDR
Present review highlights the complementary nature of different quantitative proteomic methods used to study carbapenem resistance and suggests to combine multiple proteomics methods for understanding the response to antibiotics by Acinetobacter baumannii. Expand
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
  • S. Mun, D. Joung, +8 authors D. Kwon
  • Biology, Medicine
  • Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2013
TLDR
It is suggested that curcumin reduced the MICs of several antibiotics tested, notably of OXI, AMP, CIP, and NOR, and that CCM in combination with antibiotics could lead to the development of new combination of antibiotics against MRSA infection. Expand
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
  • L. Rice
  • Biology, Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2006
TLDR
Tigecycline is a newly licensed glycylcycline that lacks activity against P. aeruginosa but has encouraging activity against many A. baumannii isolates, and can emerge during therapy, however, and is due to expression of multidrug efflux pumps. Expand
Multidrug-Resistant Acinetobacter
Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii
TLDR
Of all identified antimicrobial compounds, norwogonin was the most potent against multidrug-resistant A. baumannii strains. Expand
Phosphoproteomics as an emerging weapon to develop new antibiotics against carbapenem resistant strain of Acinetobacter baumannii.
TLDR
The proposed antibiotics selectively inhibit carbapenem resistant strain which further avoids its excessive use against carbAPenem sensitive strain and thereafter reduces emergence of resistance. Expand
Enhancing antibiotic activity: a strategy to control Acinetobacter infections.
TLDR
The activity of ellagic and tannic acids are described as adjuvants that enhance the activity of aminocoumarin antibiotics against multidrug-resistant (MDR) Acinetobacter baumannii. Expand
Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
TLDR
The global epidemiology of carbapenem-resistant A. baumannii is reviewed, with the emphasis on the molecular epidemiology and genetic characterization of carbAPenem resistance in epidemic strains. Expand
Plant-derived antimicrobial compounds: alternatives to antibiotics.
  • D. Savoia
  • Biology, Medicine
  • Future microbiology
  • 2012
TLDR
This review will focus on natural plant products as a useful source of antimicrobial molecules, active in particular, on bacteria and fungi, which are useful as alternative strategies to control infectious diseases. Expand
Antimicrobial Activity and Cytotoxic Effects of Magnolia dealbata and its Active Compounds
TLDR
The results suggest that M. dealbata and its active compounds have selective antimicrobial effects against drug-resistant fungal and Gram (-) bacteria and exert minimal toxic effects on human PMBC. Expand
...
1
2
3
4
5
...